TCS at WDSC Americas 2023: Discussing Pharmacovigilance in the AI Era

Industry

Solution

TCS at the World Drug Safety Congress Americas 2023

One of the largest congregations of pharmacovigilance (PV) professionals worldwide brought together more than 1,000 industry stakeholders in pharma to discuss key challenges in PV and device safety.

As a proud Diamond Sponsor, TCS welcomed attendees at booth #701, where our core PV leadership engaged with industry peers, showcased our deep PV transformation expertise, and demonstrated our purpose-built solution – TCS ADD™ Safety, an AI platform for pharmacovigilance.

TCS also featured in multiple speaking sessions, including a keynote panel that saw participation from speakers representing the global top 10 pharma companies. We further contributed to a track session on Next Gen Tech & Data – New Emerging Tech in PV, where inspiring POC stories and real-world applications were shared.

Key takeaways from the keynote panel discussion

The TCS ADD™ Safety team shared practical and theoretical insights on implementing pilot programs, scaling up, and maximizing efficiency with our AI-based PV platform – a solution that has been running successfully in production for over years.

During the session, we engaged participants in discussions on fundamental PV topics, explored key challenges and opportunities, and showcased next-gen technology applications to pharmacovigilance through real-life examples.

Speakers – Keynote Panel

Dr. Alejandra Guerchicoff

Industry Leader, TCS ADD™ Safety Platform

Dr. Alejandra Guerchicoff holds a Ph.D. in Molecular Genetics. At TCS, she is an Industry Advisor for the Life Sciences, TCS ADD™ platform. She has 20 years of experience in clinical research and post-marketing PV. Currently, she works on the development of innovative technology solutions with AI across various life sciences operations.

Michael Murphy

Executive Director, Head Pharmacovigilance Operation

Michael D. Murphy leads the PV operations team at Global Patient Safety, Amgen. He oversees teams that are accountable for adverse event case processing and medical review, periodic reporting, oversight of safety technologies among other things. He has over 20 years of experience in pharma, focused on PV, with expertise in change management, process excellence, and safety systems.

Joann Evangelista

Head of US Patient Safety Operations & Innovations

Joann is the Head of US Patient Safety Operations & Innovations at Genentech, with over 20 years of experience in a federally regulated landscape holding multiple positions in the Commercial and Medical Affairs organizations. She is a revered visionary leader and integrated systems thinker whose journey with Artificial Intelligence started seven years ago when AI in AE detection was at the edge of its adoption. She has cultivated an environment rich in technology using innovative approaches with AI and machine learning to sustain PV operational excellence in a rapidly changing environment. Joann’s experiences and perspective have lent itself to assess multiple AI tools across high risk PV areas to decrease exposure and increase compliance and efficiency.

Key takeaways from the fireside chat

With the ever-increasing volume of safety reports, timely handling of adverse events remains a critical challenge—one that directly impacts patient and consumer safety.

Over the past five years, rapid advancements in cognitive technologies have propelled the evolution of AI-based PV platforms. While concerns persist around information quality, accuracy in interpreting safety data, explainability of AI-driven decisions, and the investment needed for these systems, our session explored how the industry is overcoming these hurdles.

Through insightful discussions, we highlighted how AI-based PV platforms continue to advance despite these challenges, paving the way for more efficient and reliable pharmacovigilance practices.

SPEAKERS - FIRESIDE CHAT

Dr. Alejandra Guerchicoff

Industry Leader, TCS ADD™ Safety Platform

Narayanan R

Chief Architect, Head of Clinical and Safety Platform

Narayanan heads the Clinical and Safety products of the TCS ADD™ platform. He works closely with multiple pharma and biotech companies to enable the adoption of digital products and solutions to transform their drug development processes and systems.

Key takeaways from the session chair

The session explored the evolving role of AI in pharmacovigilance, focusing on how technology is addressing the mounting challenge of managing an ever-increasing volume of safety reports. Discussions highlighted persistent concerns around data quality, accuracy in interpreting safety information, explainability of AI-driven decisions, and the significant investments required to adopt these systems. Real-life examples demonstrated how AI-based PV platforms are steadily advancing, offering improved efficiency, timely case processing, and enhanced patient safety outcomes. The session underscored that, while challenges remain, the integration of cognitive technologies is reshaping pharmacovigilance into a more proactive, precise, and patient-centric discipline.

SPEAKER

Karam Veer Singh (KV)

Head of Global Markets, Solutions & Partnerships

KV has been in the industry for 20+ years, with an international experience spanning across Consulting, Technology and Business functions. In his current role at Tata Consultancy Services, he responsible for driving growth and commercial strategy of TCS ADD™ suite of Platforms, focusing on Global Markets, Solutions & Partnerships for Life Sciences & Healthcare Industries.

Dr. Alejandra Guerchicoff

Industry Leader, TCS ADD™ Safety Platform

Key takeaways from the event

Managing the growing volume of safety reports remains a critical challenge for timely and accurate adverse event handling.
Rapid adoption of cognitive technologies is reshaping pharmacovigilance practices.
AI-based PV platforms are advancing, yet concerns persist around data quality, decision explainability, and implementation costs.
Real-life use cases demonstrated improvements in efficiency, case processing speed, and patient safety outcomes.
The event encouraged knowledge sharing, innovative thinking, and strategies for the future of PV and device safety.

Thank you to everyone who stopped by to experience TCS ADD™ Safety, our purpose-built AI platform for pharmacovigilance.

Where adaptability meets advantage

We deliver excellence and create value for customers and communities.

Discover why customers choose TCS

Upcoming events

Recent recognitions

Want to be a global change-maker? Join our team.

Find the latest news about TCS

Recent News

Global knowledge. Local support

Industry

Solution

TCS at the World Drug Safety Congress Americas 2023

Key takeaways from the keynote panel discussion

Speakers – Keynote Panel

Dr. Alejandra Guerchicoff

Michael Murphy

Joann Evangelista

Key takeaways from the fireside chat

SPEAKERS - FIRESIDE CHAT

Dr. Alejandra Guerchicoff

Narayanan R

Key takeaways from the session chair

SPEAKER

Karam Veer Singh (KV)

SPEAKER

Dr. Alejandra Guerchicoff

Gallery

Image 1

Image 2

Image 3

Image 4

Image 5

Image 6

Image 7

Related reading

Transformation starts here

Find out more